Qingdao Haichuan Innovative Natural Medicine Research Center

Qingdao Haichuan Innovative Natural Medicine Research Center is a Chinese biotechnology company dedicated to the discovery and development of novel therapeutics derived from natural and marine biological resources. Based in the coastal city of Qingdao, the center focuses on the modernization of traditional medicine through high-throughput screening and advanced chemical synthesis. The company's research efforts are primarily concentrated in oncology, cardiovascular health, and anti-infective therapies. It maintains strong collaborative ties with academic institutions, particularly the Ocean University of China, to facilitate the translation of marine science into clinical drug candidates. Its lead program, HS-25, is a marine-derived small molecule that has progressed into clinical trials for the treatment of solid tumors.